New Israeli Data Shows COVID Vaccine Efficacy Plummeting To 10.8% | 220 More Hospitalized Myocarditis Cases In Boys 12-17 After Vaccination In New Study | FDA Authorizes 4th Dose | ETC
There’s been an enormous amount of news released over the past couple of days on waning vaccine efficacy, myocarditis in boys who took Pfizer & Moderna mRNA COVID vaccines, and the FDA approving a 4th dose for all 18+. If you missed reading through any of this data, it would be within your best interest to get caught up for one major reason. That being, since the FDA approved an additional dose, there will likely be more college/school, and work mandates to follow, thus increasing the rates of myopericarditis and even further.
All and all, the data has been summarized for you below. However, you should really read through the sources and not simply rely on the summaries.
New study shows myocarditis after Moderna/Pfizer was highest (1/9k)following a 2nd dose in boys aged 12-17 hospitalized with median tropinin levels of 9.9 ng/mL. Later complications from LGE likely to result in heart failure even after resolution of acute phase
https://onlinelibrary.wiley.com/doi/10.1111/eci.13759
According to a CDC MMWR release, unvaccinated individuals in California with prior infection compared to fully vaccinated with/without prior infection have equal risk of hospitalization. That said, natural immunity should earn healthcare workers a pass
https://docs.google.com/.../18YBvtF.../htmlview
Overall, In convalescent (previously infected with antibodies) & vaccinated people, geometric mean titres (GMT) against BA.2 were 1.68 times higher than against BA.1 (CI 1·63–1·73) and 2.3 times higher in those with prior infection who were also unvaccinated (95% CI 2·12-2·56). Finally, the authors state that 3 dose vaccination “had no statistical significance” on immunity. The takeaway in order:
1.) Existing antibody levels (GMTs) against BA.2 Omicron are higher than against BA.1 suggesting more robust immunity against the new Omicron variant
2.) GMTs were even higher in those unvaccinated with prior infection
3.) 2 doses and a booster provided no statistical significance in antibody protection again the new Omicron BA.2 variant
https://www.thelancet.com/.../PIIS2666-5247(22.../fulltext
FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals.
Moderna was approved for those 18+, and Pfizer for individuals 65+. The 4th dose is encouraged for those immunocompromised or those at high risk like hospital workers, and cancer patients receiving chemotherapy/bone marrow transplants.
🇫🇮 Finland
✅ 0 covid deaths in those under 20
✅ Kids 12 and under never masked
✅ Only around 10% of 5-11 year olds vaccinated
Maybe it’s time we stop taking a one size fits all vaccine & masking approach
New Israeli study on a 4th Covid dose reveals 43.1% & 30% vaccine efficacy against symptomatic disease and infection respectively with Pfizer, along with 31.4% & 10.8% vaccine efficacy against symptomatic disease and infection respectively from Moderna
https://www.nejm.org/doi/full/10.1056/NEJMc2202542
LETS CONNECT: